Jason Lettmann Alx Oncology Holdings Inc (ALXO) insider trading activity

ALXO Quotes by TradingView

Jason Lettmann is CHIEF EXECUTIVE OFFICER of ALX ONCOLOGY HOLDINGS INC. Currently has a direct ownership of 212,270 shares of ALXO, which is worth approximately $106,135. The most recent transaction as insider was on Mar 14, 2025, when has been sold 42,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 212K
25.29% 3M change
23.69% 12M change
Total Value Held $106,135

Jason Lettmann Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 14 2025
BUY
Grant, award, or other acquisition
-
42,000 Added 16.52%
212,270 Common Stock
Feb 19 2025
SELL
Open market or private sale
$2,482 $1.15 p/Share
2,159 Reduced 1.25%
170,270 Common Stock
Aug 14 2024
SELL
Payment of exercise price or tax liability
$5,652 $2.58 p/Share
2,191 Reduced 1.28%
169,429 Common Stock
Mar 14 2024
BUY
Open market or private purchase
$49,764 $11.31 p/Share
4,400 Added 2.5%
171,620 Common Stock
Feb 14 2024
BUY
Grant, award, or other acquisition
-
60,000 Added 26.41%
167,220 Common Stock
JL

Jason Lettmann

CHIEF EXECUTIVE OFFICER
Menlo Park, CA

Track Institutional and Insider Activities on ALXO

Follow ALX ONCOLOGY HOLDINGS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALXO shares.

Notify only if

Insider Trading

Get notified when an Alx Oncology Holdings Inc insider buys or sells ALXO shares.

Notify only if

News

Receive news related to ALX ONCOLOGY HOLDINGS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALXO